🔎 Trials Near Me

Gara Jalqabaatti › Scleroderma › New York › New York City

Qorannoo klinikaalii Scleroderma New York City, NY keessatti

Qorannoo 11 Scleroderma f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Namoota walitti qabaa jiraSadarkaa 1
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • NYP/Weill Cornell Medical Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Namoota walitti qabaa jiraSadarkaa 3
  • Hospital for Special Surgery, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University Medical Center-New York Presbyterian Hospital, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07497087

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Namoota walitti qabaa jiraSadarkaa 1
  • Icahn School of Medicine at Mount Sinai, New York
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Namoota walitti qabaa jiraSadarkaa 2/3
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05878717

Platform Clinical Study for Conquering Scleroderma

Namoota walitti qabaa jiraSadarkaa 2
  • Hospital for Special Surgery, New York
  • Columbia University Medical Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Namoota walitti qabaa jiraSadarkaa 2/3
  • Columbia University Irving Medical Center, New York
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06328777

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Nkarta Investigational Site, New York
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06733935

A Study of AZD0120 in Autoimmune Diseases

Namoota walitti qabaa jiraSadarkaa 1
  • Research Site, New York
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07295847

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Namoota walitti qabaa jiraSadarkaa 1
  • Montefiore Medical Center, New York
Umuriin 12 hanga 70 · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT06308978

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Namoota walitti qabaa jiraSadarkaa 2
  • Hospital for Special Surgery, New York
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT03844061

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Namoota walitti qabaa jiraSadarkaa 2
  • aTyr Investigative Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Cam-2025 · NCT05892614

Qorannoo Scleroderma magaalota biroo keessatti

Qorannoo biroo New York City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.